Literature DB >> 24333404

Mechanisms and treatments for renal artery stenosis.

Steven T Haller1, Kaleigh L Evans, David A Folt, Christopher A Drummond, Christopher J Cooper.   

Abstract

Atherosclerotic renal artery stenosis (ARAS) is a common and complicated disease, which can result in high blood pressure and loss of kidney function. Although progress has been made in the understanding and treatment of hypertension in relation to ARAS, much less progress has been made in the area of renal function. Here we discuss current treatment options in regard to medical therapy and revascularization. We also describe the proposed mechanisms leading to renal dysfunction, including the CD40 signaling cascade, which is a particularly attractive signaling mechanism that may provide a mechanistic rationale for the development of renal disease in ARAS.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24333404

Source DB:  PubMed          Journal:  Discov Med        ISSN: 1539-6509            Impact factor:   2.970


  3 in total

1.  Mood Disorders in Uncontrolled Hypertension Despite Multiple Anti-Hypertensive Medications: Searching for a Link.

Authors:  Alberto Mazza; Roberta Ravenni; Michela Armigliato; Ciro Rossetti; Laura Schiavon; Fulvio Fiorini; Gianluca Rigatelli; Emilio Ramazzina; Edoardo Casiglia
Journal:  High Blood Press Cardiovasc Prev       Date:  2016-01-04

2.  Delivery of miR-654-5p via SonoVue Microbubble Ultrasound Inhibits Proliferation, Migration, and Invasion of Vascular Smooth Muscle Cells and Arterial Thrombosis and Stenosis through Targeting TCF21.

Authors:  Tao Wang; Xiaoqiang Tang; Yong Zhang; Xiaoqin Wang; Haifeng Shi; Ruohan Yin; Changjie Pan
Journal:  Oxid Med Cell Longev       Date:  2022-07-19       Impact factor: 7.310

3.  Cortical and medullary oxygenation evaluation of kidneys with renal artery stenosis by BOLD-MRI.

Authors:  Long Zhao; Guoqi Li; Fanyu Meng; Zhonghua Sun; Jiayi Liu
Journal:  PLoS One       Date:  2022-03-10       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.